Investor Relations

WHEN:      

Thursday, April 15, 2021
10 a.m. – 1:30 p.m. EDT | 2 p.m. – 5:30 p.m. GMT | Virtual video event

WHERE:       

To register for the event, click here: https://covidsciencesummit.com/.
You will receive an email with a webcast link prior to the start of the event.

Attendees are invited to submit questions for panelists prior to the event at https://covidsciencesummit.com/.

WHAT:         

The 2021 Global Scientific Summit on COVID-19 is being hosted by Carnival Corporation and WTTC, as well as supporting sponsors Hilton Worldwide Holdings and the U.S. Travel Association. The virtual event will explore the most up-to-date science on COVID-19 to inform practical approaches and best practices for moving beyond the pandemic.

The event will focus on the most up-to-date science amassed from the past year of studying COVID-19, including how best to address the many ongoing questions about how the virus will affect society, travel and day-to-day activities moving forward. The Summit will feature world-renowned medical, epidemiological and public health experts to explore and share recent findings and daily practices to curb the spread of COVID-19 in a post-pandemic future.

Panels will include fact-based discussions sharing the latest insights on epidemiology, screening, testing and tracing, therapeutics, vaccines, practical prevention and mitigation practices and more, including:

• The Science of COVID-19:  Epidemiology; Transmission; Testing.
• Treatment & Prevention:  Masks, Surfaces and Physical Distancing; Isolation and Quarantine; Vaccines; Therapeutics.
• Life in a World with COVID-19:  Practicality; Adapting; Risk Mitigation.

The event is designed for the general public, and it is free to attend all or parts of the discussion. Registration is now open at https://covidsciencesummit.com/.

WHO: 

The virtual Summit is hosted by World Travel & Tourism Council (WTTC), which represents the global travel and tourism private sector, and Carnival Corporation, the world's largest cruise company. Hilton Worldwide Holdings and the U.S. Travel Association are supporting sponsors of the event. Moderators include:

• Arnold Donald, president & CEO, Carnival Corporation 
• Gloria Guevara, president & CEO, WTTC

WHO (cont'd): 

Donald and Guevara will encourage straightforward, easy-to-understand and fact-based discussions sharing the latest insights on epidemiology, screening, testing and tracing, therapeutics, vaccines, practical prevention and mitigation practices and more. Panelists include (in alphabetical order):

• Dr. Michael Diamond, M.D., Ph.D., the Herbert S. Gasser Professor of Medicine at Washington University. Dr. Diamond is recognized internationally for his work involving Zika, West Nile, chikungunya, and related emerging viruses.
• Dr. Steven Gordon, M.D., chairman, department of infectious disease, Cleveland Clinic, Respiratory Institute and professor of medicine, The Lerner College of Medicine, Case Western University. Dr. Gordon has been focused on hospital infection prevention, including device-associated and opportunistic infections in immunocompromised patients.
• Dr. Michael Lin, M.D., Ph.D. is Associate Professor of Neurobiology, Bioengineering, and Chemical and Systems Biology at Stanford University. A NIH Pioneer Award recipient, Dr. Lin develops protein-based tools for molecular imaging and control of gene and viral therapy. 
• Dr. William Morice, II, M.D., Ph.D., chair, department of laboratory medicine and pathology at Mayo Clinic, president, Mayo Clinic Laboratories, and professor of laboratory medicine and pathology. Dr. Morice is an expert in diagnostic testing serving in leadership roles for numerous boards and partnerships to enhance understanding of clinical diagnostics and test utilization.
• Dr. Jewel Mullen, M.D., M.P.H., associate dean for health equity, University of Texas at Austin, Dell Medical School. Dr. Mullen is an internist, epidemiologist and public health physician leader and the former principal deputy assistant secretary for health in the U.S. Department of Health and Human Services (HHS).
• Dr. Emil Christian Reisinger, director of the Department of Tropical Medicine and Infectious Diseases at the Department of Internal Medicine at the University of Rostock, Dean of the University and Member of the Board of the University Hospital Rostock.
• Dr. Clare Rock, M.D., M.S., Associate Professor of Medicine, Associate Hospital Epidemiologist, Johns Hopkins University School of Medicine.  Dr. Rock has significant expertise in institutional COVID-19 support, including as Hospital Epidemiology and Infection Control COVID-19 Johns Hopkins Health System Incident Commander. Specific expertise and experience include COVID-19 testing strategies for the workplace, businesses, & community, return to work policies, return to business strategies, outbreak and cluster management, contact tracing, addressing COVID-19 vaccine hesitancy in the workplace and the community.
• Dr. Stefano Vella, Adjunct Professor of Global Health at the Catholic University of Rome and a member of the Program Committee of Horizon Europe - Health Cluster, the Research Program of the European Commission. Dr. Vella specializes in infectious diseases and internal medicine and is a researcher in pathogenesis and therapy of viral infections. Specific research has been conducted by Dr. Vella on major pandemics, specifically on HIV/AIDS and Tuberculosis.

NEXT STEP:   

Register for the event at:  https://covidsciencesummit.com/.